NUVL · As filed with the SEC
Nuvalent balance sheet, by fiscal year
The statement as Nuvalent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD
| USD | FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 | FY2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | 261,745,000 | 145,691,000 | 335,387,000 | 241,806,000 | 68,526,000 | 10,332,000 |
| Marketable securities | 1,110,207,000 | 972,611,000 | 384,518,000 | 230,357,000 | 219,585,000 | 0 |
| Prepaid expenses and other current assets | 20,474,000 | 14,146,000 | 6,583,000 | 5,828,000 | 2,517,000 | 314,000 |
| Total current assets | 1,392,426,000 | 1,132,448,000 | 726,488,000 | 477,991,000 | 290,628,000 | 10,646,000 |
| Other assets | 20,279,000 | 9,304,000 | 5,896,000 | 4,468,000 | 3,196,000 | — |
| Total assets | 1,412,705,000 | 1,141,752,000 | 732,384,000 | 482,459,000 | 293,824,000 | 10,646,000 |
| Liabilities and Stockholders' Equity | ||||||
| Current liabilities: | ||||||
| Accounts payable | 30,158,000 | 5,225,000 | 9,274,000 | 7,195,000 | 2,893,000 | 1,252,000 |
| Accrued expenses | — | 48,795,000 | 22,549,000 | 12,286,000 | 5,894,000 | 1,171,000 |
| Preferred stock tranche rights | — | — | — | — | — | 1,957,000 |
| Accrued expenses and other current liabilities | 61,013,000 | — | — | — | — | — |
| Total current liabilities | 91,171,000 | 54,020,000 | 31,823,000 | 19,481,000 | 8,787,000 | 4,380,000 |
| Notes payable and accrued interest to stockholder | — | — | — | — | — | 2,235,000 |
| Related party revenue share liability | 73,160,000 | 17,940,000 | — | — | — | — |
| Other liabilities | 35,000 | — | — | — | — | — |
| Total liabilities | 164,366,000 | 71,960,000 | 31,823,000 | 19,481,000 | 8,787,000 | 6,615,000 |
| Convertible preferred stock (Series A and B), $0.0001 par value; no shares and 112,431,508 shares authorized at December 31, 2021 and 2020, respectively; no shares and 89,945,206 shares issued and outstanding at December 31, 2021 and 2020, respectively; | — | — | — | — | — | 35,354,000 |
| Stockholders' equity: | ||||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding | 0 | 0 | 0 | 0 | — | — |
| Common Class A | 7,000 | 7,000 | 6,000 | 5,000 | 4,000 | — |
| Common Class B | — | — | 1,000 | 1,000 | 1,000 | — |
| Class B Convertible Common Stock | 1,000 | 1,000 | — | — | — | — |
| Additional paid-in capital | 2,218,407,000 | 1,616,895,000 | 986,819,000 | 623,543,000 | 363,483,000 | 842,000 |
| Accumulated other comprehensive income (loss) | 2,353,000 | (59,000) | 31,000 | (494,000) | (228,000) | — |
| Accumulated deficit | (972,429,000) | (547,052,000) | (286,296,000) | (160,077,000) | (78,223,000) | (31,885,000) |
| Promissory note from stockholder | — | — | — | — | — | (280,000) |
| Total stockholders' equity | 1,248,339,000 | 1,069,792,000 | 700,561,000 | 462,978,000 | 285,037,000 | (31,323,000) |
| Total liabilities and stockholders' equity | 1,412,705,000 | 1,141,752,000 | 732,384,000 | 482,459,000 | 293,824,000 | 10,646,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.